The company agreed to pay nearly $9 billion to settle lawsuits accusing its talc baby powder of causing cancer.& Johnson is trying once again to use the bankruptcy courts to settle tens of thousands of cases that claim its talc products cause cancer. The pharmaceutical company is now willing to pay $8.
& Johnson's worldwide vice president of litigation, in a statement. "However, as the bankruptcy court recognized, resolving these cases in the tort system would take decades and impose significant costs on LTL and the system."
Should be 50b n bankrupt them
This is in addition to their lawsuit against them for their baby shampoo. Sick company
เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
Johnson & Johnson stock up 3% as company sets aside $8.9 billion to settle talc claimsJohnson & Johnson stock rose nearly 3% in the extended session Tuesday after the company said it was setting aside $8.9 billion to settle claims connected...
แหล่ง: MarketWatch - 🏆 3. / 97 อ่านเพิ่มเติม »
Johnson & Johnson shares rise after company proposes baby powder cancer settlementWall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.
แหล่ง: CNBC - 🏆 12. / 72 อ่านเพิ่มเติม »
Johnson & Johnson talc settlement: Company willing to pay $8.9B for baby powder cancer lawsuitsJohnson & Johnson has agreed to pay nearly $9 billion to settle lawsuits accusing its talc baby powder of causing cancer. Imagine what could have been in those Johnson and Johnson Covid vaccines?
แหล่ง: ABC7Chicago - 🏆 284. / 63 อ่านเพิ่มเติม »
Johnson & Johnson talc settlement: Company willing to pay $8.9B for baby powder cancer lawsuitsJohnson & Johnson has agreed to pay nearly $9 billion to settle lawsuits accusing its talc baby powder of causing cancer. 9 billion ain’t shit
แหล่ง: abc7newsbayarea - 🏆 529. / 51 อ่านเพิ่มเติม »